Radical concurrent chemoradiotherapy
WebTreatment with radical concurrent chemoradiotherapy and immunotherapy was continued. Involved-field irradiation (IFI) was used for the delineation of target volumes to achieve targeted irradiation of the primary tumors and lymph node metastases. Considering that high irradiation doses might increase the risk of gastric perforation in the ... WebDespite current treatment strategies, the 5-year overall survival of muscle-invasive bladder cancer (MIBC) is approximately 50%. Historically, radical cystectomy (RC) with neoadjuvant chemotherapy has been the first-choice treatment for this patient group. Recently, several studies have reported encouraging results of using immune checkpoint inhibitors (ICI) …
Radical concurrent chemoradiotherapy
Did you know?
WebJul 9, 2024 · In inoperable Stage III NSCLC, consolidation immune checkpoint inhibition with the PD-L1 inhibitor durvalumab after completion of concurrent platinum-based chemoradiotherapy resulted in remarkable improvement of progression-free and overall survival. This new tri-modal therapy has become a new treatment standard. WebMar 1, 2011 · A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin–docetaxel, plus radical concurrent chemoradiotherapy with cisplatin–docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer. ... Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane …
WebMar 19, 2024 · Results: Compared with sequential chemoradiotherapy, concurrent chemoradiotherapy did not increase the 1-year survival rates; however, concurrent … WebApr 5, 2024 · A phase III study of concurrent chemoradiotherapy with or without consolidation docetaxel in stage III NSCLC was terminated early as the group receiving docetaxel showed excessive grade 3–5 toxicity (28.8% vs. 8.1%) compared to the observation arm, and the median survival was 21.2 months in the group receiving …
WebMar 24, 2024 · This study aimed to assess neoadjuvant chemotherapy’s clinical outcomes such as efficacy, toxicity, and survival outcomes followed by radical hysterectomy ((NACT-RS) among women with cervical cancer stage IB3 and IIA2, by comparing concurrent chemoradiotherapy (CCRT) and NACT-RS. The study retrospectively reviewed patients … WebJan 24, 2024 · The real-world study suggests that concurrent chemoradiotherapy significantly improves OS compared with radiotherapy alone after palliative chemotherapy in patients with de novo metastatic nasopharyngeal carcinoma. More specifically, concurrent chemoradiotherapy with single-agent platinum after 4–6 cycles of chemotherapy can be …
WebMay 25, 2024 · All the patients received platinum-based radical concurrent chemoradiotherapy and were divided into two groups: adjuvant chemotherapy after CCRT …
WebMay 23, 2024 · Concurrent chemoradiotherapy (comprising external beam radiotherapy and brachytherapy, with concurrent cisplatin or carboplatin) is the standard of care for the treatment of locally advanced cervical cancer. ... Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. how to buy vectorspace aiWebDespite current treatment strategies, the 5-year overall survival of muscle-invasive bladder cancer (MIBC) is approximately 50%. Historically, radical cystectomy (RC) with … how to buy vbucks with xbox on pcWebConcurrent chemoradiotherapy is a highly efficacious locoregional treatment option for solid tumors. meyerson dallas seating chartWebApr 11, 2024 · Histologically or cytologically proven nasopharyngeal carcinoma and was defined as stage IVb by AJCC (8th edition) or recurrent nasopharyngeal carcinoma patients that are not suitable for topical treatment (For neoadjuvant/adjuvant treatment and radical concurrent chemoradiotherapy, if the disease progress during treatment or within 6 … meyerson foxWebConcurrent cisplatin-based chemoradiotherapy is the standard treatment for locally advanced cervical carcinoma (LACC) based on five clinical trials (GOG85, Radiation Therapy Oncology Group [RTOG] 9001, GOG123, GOG120, SWOG 8797) and two meta-analyses. 1, 2 However, the 5-year survival of patients with LACC is still around 70%. 3 In the GOG123 tr... meyerson hall facilitiesWebMay 25, 2024 · All the patients received platinum-based radical concurrent chemoradiotherapy and were divided into two groups: adjuvant chemotherapy after CCRT (CCRT+ACT group) and observation after CCRT (CCRT group). Overall survival (OS), progression free survival (PFS) and adverse effects were recorded and analyzed. meyerson family foundationWebJun 1, 2024 · The evaluation of tumor response after concurrent chemoradiotherapy (CCRT) by using various imaging modalities, such as endoscopic rectal ultrasound (EUS), computed tomography (CT), and magnetic resonance imaging (MRI), in the preoperative setting is controversial [1,2,3].MRI is the gold standard diagnostic modality in evaluating the stage … how to buy vbucks with gcash